Acclinate Logo
Talk to Our Team

Birmingham, AL ( April 18, 2022) - Acclinate, a leading digital health company, announced the appointment of Camille Pope, PharmD as Chief Medical Lead. She brings 14+ years of pharmaceutical industry experience to the company. In this role, Camille will oversee all medical and scientific communication between community members and pharmaceutical industry/healthcare partners. She will also contribute strategic market intelligence to help further develop Acclinate’s platform and services.  

“Acclinate has made great strides in building a world-class team and developing innovative technologies to drive sustained community engagement leading to greater clinical trial diversity," said Dr. Pope. "I'm thrilled to join the Acclinate team and work with such a talented group of individuals on our quest to achieve health equity through inclusive research".

With experience in medical affairs across several therapeutic areas, Camille is a proven pharmaceutical industry leader with extensive drug launch experience. Before joining Acclinate, Camille served as the US Medical Lead for Prostate Cancer at AstraZeneca and as a Senior MedicalScience Liaison for Hepatitis C & HIV at Abbvie. She was recognized for her leadership by AstraZeneca's Rising Leaders Program and the She-Suite BrandLeadership Institute.

"Camille is a key leadership addition to our team," said Del Smith, CEO and co-founder of Acclinate. "Her extensive domain knowledge and demonstrated passion for health equity will be a tremendous asset as we continue to scale."

As an experienced healthcare professional with demonstrated expertise in diversity and inclusion, Camille is enthusiastic about fostering diverse talent and striving for health equity. She has championed several projects to address clinical trial diversity gaps and established  AstraZeneca's US Medical Oncology Inclusion& Diversity Talent Recruitment Workstream, which led to new partnerships with Howard University’s College of Pharmacy and the Tom Joyner Foundation.

"Acclinate continues to break down barriers for communities of color in the clinical trial space and create a more robust and efficient process for researchers and sponsors," said CDO and co-founder Tiffany Whitlow. "Leading the charge in diversifying clinical trials requires a top-tier team that exhibits leadership. I look forward to working with Camille to implement innovative strategies that will help us scale and enhance our offering.

Camille holds a Doctor of Pharmacy degree from Florida Agricultural and Mechanical University. She completed a Post-Doctoral Medical Strategy Fellowship with Bristol-Myers Squibb/Rutgers Institute for Pharmaceutical Industry Fellowships. Camille is currently earning her graduate certificate in Health Disparities Research from the University of Illinois Chicago.

_____________

About Acclinate™

Acclinate™ is a Birmingham-based digital health company helping pharmaceutical companies and healthcare organizations access and engage communities of color so that research is more inclusive.

Recent Posts

 The Launch Lens: Weaving Community Engagement Throughout Drug Development & Commercialization
4 Min Read

We pour our efforts into research, striving for breakthroughs that change lives. But are we truly listening to the people who those breakthroughs are ...

Read More
The Case for Inclusive Research in Times of Uncertainty
3 Min Read

Any time an administration changes hands, industries across the country brace for shifts in policy and regulatory oversight. This is particularly true...

Read More
Inclusive Research: The Key to a Healthier America
3 Min Read

Research has the power to transform lives. It’s the driving force behind medical breakthroughs, public health improvements, and overall well-being. Bu...

Read More
From Study-Specific to Therapeutic Area Sustained Community Engagement
4 Min Read

The pharmaceutical industry faces significant challenges in clinical trial recruitment and retention—often struggling with timelines, cost overruns, a...

Read More
Representation in Healthcare: A Win for Research, Not Just for People
4 Min Read

Key Takeaways and Learnings Stronger clinical research depends on including a wide range of participants to ensure treatments, including targeted ther...

Read More
patient and doctor talking
5 Min Read

Key Takeaways and Learnings The recent FDA diversity in clinical trials guidance emphasizes how sponsors plan on reaching specific representation goal...

Read More
Representation Matters: Improving Health Equity - SXSW 2024
39 Min Read

Key Takeaways and Learnings Inclusive clinical trials are essential to addressing health disparities in underrepresented communities. Building trust t...

Read More
Quilt AI: Acclinate Partnership Spotlight
6 Min Read

Key Takeaways and Learnings Engaging communities through trusted relationships fosters meaningful participation in research. AI and predictive analyti...

Read More
Health Equity Solutions: Leveraging Data to Improve Diverse Patient Recruitment
3 Min Read

Key Takeaways and Learnings As advanced data analytics and AI take hold in healthcare, sponsors shouldn’t overlook the potential to predict who will e...

Read More